What Is Everlywell? Tests, Costs, and Results

Everlywell is a direct-to-consumer health testing company that sells at-home lab test kits covering areas like thyroid function, cholesterol, sexually transmitted infections, food sensitivities, hormone levels, and more. Founded in 2015 and based in Austin, Texas, the company ships collection kits to your door, you provide a sample (usually a finger-prick blood spot, urine, or swab), mail it to a partner lab, and receive physician-reviewed results through an online dashboard, typically within a few business days. Prices generally fall between $49 and $249 per test, though bundles and membership plans shift the math. The appeal is obvious: skip the doctor’s visit, skip the waiting room, get answers on your own schedule. Whether those answers are as useful as the ones you would get through traditional clinical channels is a more complicated question.

How the Collection Process Works

Everlywell kits arrive with everything you need for sample collection: lancets for finger-prick blood draws, swabs for vaginal or throat specimens, urine cups, or saliva tubes, depending on the test. For blood-based tests, you prick your finger, apply drops of blood to a specially treated card (called a dried blood spot card), let it dry, and mail it back in a prepaid envelope. STI tests typically use self-collected swabs or urine. Hormone and cortisol tests sometimes rely on saliva samples collected at specific times of day.

The dried blood spot method is the backbone of many Everlywell kits. It is not new technology. Newborn screening programs have used dried blood spots for decades to detect metabolic and thyroid disorders. The advantage is stability: dried blood samples can survive several days at a range of temperatures during shipping without degrading to the point of uselessness. One study examining thyroid-stimulating hormone (TSH) in dried blood spots found the samples remained stable for at least four days at temperatures ranging from −20°C to +30°C.¹ That stability is what makes mail-order blood testing practical.

Once the sample reaches the partner laboratory, it is processed using the same types of immunoassay analyzers and molecular testing platforms found in traditional clinical labs. The labs Everlywell partners with are required to hold certifications under federal standards designed to ensure reproducible and reliable results.² An independent physician licensed in your state reviews the results before they are released to you through the Everlywell platform.

What Tests Are Available

Everlywell’s catalog has expanded considerably since the company launched. As of recent listings, it includes several dozen individual tests and bundled panels spanning a wide range of health categories. Some of the most popular options fall into a few broad groups:

Thyroid: Measures TSH alone or alongside free T3, free T4, and thyroid antibodies to screen for underactive or overactive thyroid function.
Cholesterol and heart health: Lipid panels measuring total cholesterol, HDL, LDL, and triglycerides.
STI screening: Individual tests or panels covering chlamydia, gonorrhea, trichomoniasis, HIV, hepatitis C, herpes, and syphilis, using urine or self-collected swabs.
Food sensitivity: Measures IgG reactivity to a panel of common foods (distinct from a clinical food allergy test, which measures IgE).
Hormones: Includes women’s health panels (estrogen, progesterone, LH, FSH), men’s testosterone, and cortisol (stress hormone) tests.
Vitamins and metabolism: Vitamin D, vitamin B12, iron, HbA1c (a marker for blood sugar control over time), and inflammation markers like hsCRP.

Prices vary by complexity. A single-marker test like Vitamin D or HbA1c tends to sit around $49. Multi-marker panels, such as a comprehensive thyroid panel or a full STI panel, typically range from $99 to $199. More extensive bundles or wellness packages can push past $250. Everlywell also offers a monthly membership (branded as Everlywell+) that gives a discount on tests and sometimes includes a set number of tests per year. The membership changes the per-test math if you plan to test repeatedly, though it is worth checking whether your particular tests are eligible before signing up.

Insurance does not typically cover Everlywell kits. Some people use HSA or FSA funds, which Everlywell says it accepts, but you should confirm with your specific plan. By comparison, many of the same tests ordered through a doctor and run through insurance might cost you only a copay, though the convenience factor disappears when you factor in scheduling, waiting rooms, and lab visits.

How Accurate Are Dried Blood Spot Results

The question most people have about at-home testing is straightforward: can a few drops of blood on a card really match what a full venous blood draw would show? For several well-studied markers, the answer is surprisingly close to yes.

Thyroid testing offers one of the clearest examples. A study comparing TSH measured from finger-stick dried blood spots against standard venous plasma found a correlation of 0.988, meaning the two methods tracked almost perfectly. That level of agreement allowed correct identification of both low and high thyroid function in the vast majority of cases, with no false positives.¹ An earlier study comparing dried blood spot and serum TSH across more than a hundred matched specimens found a correlation coefficient of 0.99.³

Point-of-care and fingerstick-based devices more broadly have shown good agreement with standard lab assays. In a study evaluating several such devices against traditional clinical chemistry methods, at least 95% of all samples fell within acceptable limits of agreement for each device tested.⁴ That is a reassuring number, though it also means a small percentage of samples will produce results that differ meaningfully from what a standard blood draw would show.

There are real limitations. The volume of blood in a dried blood spot is tiny compared to a venous sample, which makes the result more sensitive to collection technique. How hard you squeeze your finger, how hydrated you are, and your hematocrit (the proportion of red blood cells in your blood) can all influence the measurement. Research on dried blood spot TSH specifically has shown that higher hematocrit levels push TSH readings slightly lower.⁵ For most people, this effect is small enough that it does not change the clinical interpretation, but for someone whose true value sits right at the border between normal and abnormal, it could tip the result one way or the other.

STI Testing at Home

Sexually transmitted infection testing is one of the more popular categories for at-home kits, and for good reason: STI screening has long suffered from access barriers related to stigma, inconvenient clinic hours, and cost. The scientific question is whether self-collected specimens gathered at home produce results as reliable as those collected by a healthcare provider in a clinical setting.

A large systematic review and meta-analysis of at-home specimen self-collection for chlamydia and gonorrhea found high concordance between home-collected and clinic-collected specimens. For chlamydia specifically, concordance ran above 96% regardless of whether vaginal swabs, urine, or pooled specimens were used. The linkage to follow-up care was also not significantly different between the two settings.⁶ In practical terms, sending a swab from your bathroom is about as accurate as having a nurse collect it in a clinic.

The picture holds up even for harder-to-reach sites. A validation study comparing provider-collected and self-collected rectal and throat swabs for chlamydia and gonorrhea found positive percent agreement ranging from about 91% to 100%. When discrepancies did occur, the self-collected specimens were actually more likely to catch an infection the provider-collected sample missed, not the other way around.⁷ That counterintuitive finding probably reflects the fact that people are sometimes more thorough when swabbing themselves without the self-consciousness of a clinical encounter.

Blood-based STI tests for HIV, hepatitis C, herpes, and syphilis rely on antibody detection rather than swab-based molecular testing, and the dried blood spot method carries its own set of accuracy considerations. Window periods still apply: if you were exposed very recently, antibodies may not have developed yet, and the test will come back negative regardless of how accurate the assay is. Everlywell’s materials note these window periods, but it is easy to overlook the fine print when you are anxious about a recent exposure.

The Food Sensitivity Question

Everlywell’s food sensitivity test is one of its best-known products, and it is also the most scientifically contentious. The test measures immunoglobulin G (IgG) reactivity to a panel of roughly 96 foods. If your blood shows elevated IgG levels against, say, eggs or dairy, the test flags those foods as potential sensitivities.

The problem is that the medical and allergy communities broadly agree that IgG reactivity to foods is a normal part of immune function and does not reliably indicate a sensitivity or intolerance. When allergists diagnose food allergies, they rely on IgE testing, skin prick tests, and clinical challenge protocols, not IgG panels.⁸ IgE is the antibody involved in true allergic reactions, the kind that can cause hives, swelling, or anaphylaxis. IgG, by contrast, tends to rise in response to foods you eat regularly. High IgG to eggs may simply mean you eat a lot of eggs.

This does not mean the test is useless to everyone. Some people use the results as a starting point for elimination diets, removing flagged foods for a few weeks and then reintroducing them one at a time to see if symptoms change. That approach can be genuinely helpful for people dealing with vague digestive complaints, but the value comes from the structured elimination process, not from the IgG numbers themselves. The test provides a list of candidates to try removing; it does not diagnose a condition. If you go in expecting a clinical diagnosis, you will be disappointed. If you go in looking for a structured way to experiment with your diet, it can serve that purpose, with the understanding that the science behind the specific rankings is weak.

What Happens After You Get Results

Everlywell delivers results through an online portal, typically within five to seven business days. Each result includes a marker-by-marker breakdown showing where your values fall relative to reference ranges, along with brief explanations of what each marker means. A physician reviews the results before release, and if anything comes back significantly abnormal, Everlywell may flag it and recommend you follow up with your own healthcare provider.

The follow-up recommendation is where the direct-to-consumer model runs into friction. You have a number on a screen. You know it is flagged as high or low. But you do not have a doctor sitting across from you putting that number into the context of your symptoms, medical history, and medications. A mildly elevated TSH, for example, could mean subclinical hypothyroidism that needs monitoring, or it could mean you took the test at a time of day when TSH is naturally higher, or it could mean your hematocrit slightly distorted the dried blood spot reading. Without a clinician to weigh those possibilities, you are left to Google, and Google is not known for nuanced medical interpretation.

This gap matters in both directions. A review in Clinical Chemistry examining direct-to-consumer testing broadly found only limited evidence that DTC test results have led to measurably improved health outcomes.⁹ The tests produce data, but data without clinical context does not automatically translate into better health decisions. Some people will take an abnormal result to their doctor and get appropriately worked up. Others will see a normal result and assume they are fine when their symptoms warrant further investigation.

Anxiety, False Reassurance, and the Psychology of Self-Testing

One underappreciated dimension of at-home testing is the psychological impact of receiving your own lab results without professional guidance. A concern raised consistently in the medical literature is that direct-to-consumer testing can generate both anxiety and false reassurance, depending on the result and the person receiving it.¹⁰

Anxiety is the more obvious risk. A borderline result, or even a normal result accompanied by unfamiliar medical terminology, can send a health-anxious person into a spiral of worry that would not have occurred if they had never tested. The opposite problem is subtler but equally concerning: a clean set of results can create a sense of “all clear” that delays a visit to a doctor for symptoms that genuinely need evaluation. A normal cholesterol panel does not rule out heart disease. A negative STI test taken too soon after exposure does not mean you are in the clear. These are the kinds of caveats that a clinician would explain in person but that a results dashboard handles with small-print disclaimers.

People who tend to do well with at-home testing are generally those who have a specific, concrete question (is my thyroid working, do I have chlamydia, is my vitamin D low), who understand that the result is a screening tool rather than a definitive diagnosis, and who have a primary care provider they can take the results to. People who are using the tests to manage general health anxiety, or who plan to make major dietary or supplement changes based solely on the results, tend to get less value and more confusion from the process.

Regulatory Oversight and Lab Standards

Everlywell itself is not a laboratory. It is a platform that connects consumers with partner labs, which are the entities subject to federal regulation. Those labs must comply with the Clinical Laboratory Improvement Amendments (CLIA), a set of federal standards that govern any facility testing human samples. Many also hold accreditation from the College of American Pathologists (CAP), which adds an additional layer of proficiency testing and inspections.²

The regulatory picture for the tests themselves is more complicated. Many of the assays used by direct-to-consumer testing companies are classified as laboratory-developed tests (LDTs), which are tests designed and validated within a single lab rather than sold commercially as pre-packaged kits. The FDA has historically taken a hands-off approach to LDTs, allowing labs to develop and offer them without going through the agency’s formal clearance or approval process. That stance has been shifting, with the FDA publishing a final rule that moves toward more active oversight of LDTs.¹¹ What this will mean in practice for companies like Everlywell is still playing out, but it could eventually require more rigorous validation for some of the tests on offer.

For the consumer, the practical takeaway is that the labs running your sample are held to real standards, the same standards that apply to the lab your doctor uses. The tests themselves, however, vary in how thoroughly they have been validated for the specific at-home collection method. Well-studied markers like TSH and chlamydia have strong data supporting dried blood spot and self-swab accuracy. Newer or less common panels may have thinner evidence behind them.

Who Benefits Most from At-Home Testing

The strongest case for services like Everlywell is access. If you live in a rural area without a nearby lab, work hours that conflict with clinic schedules, lack insurance, or face barriers related to stigma (particularly for STI testing), at-home kits solve a real problem. Research into nonfasting cholesterol testing using fingerstick samples and machine-learning-based LDL calculation has suggested that enabling testing at retail pharmacies and through home kits could eliminate thousands of repeat fasting visits per ten thousand tests, translating to meaningful savings in both direct healthcare costs and patient time and travel expenses.¹²

For STI screening specifically, the at-home option may actually increase testing rates among populations that would otherwise go unscreened. The high concordance between home-collected and clinically collected specimens makes this a genuinely viable public health strategy, not just a convenience product.⁶

The weakest case is for someone who already has a primary care relationship, good insurance, and easy access to a lab. In that situation, you are paying out of pocket for a less comprehensive version of something your doctor could order with a copay. You also lose the clinical context that makes test results actionable. Where Everlywell sits on that spectrum for you depends on your specific circumstances, not on whether the technology works in the abstract.

Common Misconceptions Worth Clearing Up

A few beliefs about at-home testing circulate widely enough to be worth addressing directly. The first is that these tests are less accurate because they are done at home. As the research on dried blood spots and self-collected specimens shows, the lab processing is identical to what happens with provider-collected samples. The potential accuracy gap comes from the collection step, not the analysis. If you follow the instructions carefully, the lab receives a usable sample and runs it on the same equipment it uses for hospital orders.

The second misconception runs in the opposite direction: that an at-home test result is equivalent to a clinical diagnosis. It is not. These are screening tools. A positive result means something worth investigating; it does not confirm a disease. A negative result means the marker in question was not detected at the time of testing; it does not guarantee you are healthy. This distinction is especially relevant for STI panels (window periods) and thyroid tests (TSH fluctuates throughout the day and in response to illness, stress, and medications).

The third is that food sensitivity tests reveal food allergies. As discussed above, IgG-based food sensitivity panels measure something biologically real but clinically ambiguous. They are not allergy tests, and treating them as such can lead people to unnecessarily restrict their diets in ways that reduce nutritional variety without resolving symptoms. If you suspect a true food allergy involving reactions like hives, throat tightening, or digestive distress after specific foods, you need IgE-based testing and possibly an oral food challenge supervised by an allergist, not a mail-order IgG panel.

Comparing Everlywell to Other At-Home Testing Services

Everlywell is the most widely recognized name in direct-to-consumer lab testing, but it operates in a growing market. Competitors include LetsGetChecked, myLAB Box, and several others that follow a broadly similar model: kit shipped to you, sample mailed back, results delivered online. The core technology and lab standards are comparable across these services, since they all use CLIA-certified labs.

Where the services differ is in test selection, pricing, user experience, and follow-up support. Some competitors include a telehealth consultation with a clinician as part of the test price, which partially addresses the context gap. Others focus on specific niches, like fertility testing or men’s health panels. Everlywell’s advantage is breadth of catalog and brand recognition, but a narrower competitor might offer a better deal or better support for the specific test you need. Price comparison is worth the effort, since the underlying lab work is often similar and markups vary.

Employer wellness programs and some health systems have also started incorporating at-home collection kits into their offerings, sometimes at reduced or no cost to the patient. If your employer or insurer offers something like this, it may be worth exploring before paying retail for an Everlywell kit, since the lab quality will be equivalent and the results may flow directly into your medical record, which makes follow-up easier.